ETC
EGRX
Exchange Traded Concepts’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-23,209
| Closed | -$366K | – | 1436 |
|
|
2023
Q3 | $366K | Buy |
+23,209
| New | +$366K | 0.01% | 712 |
|
|
2023
Q1 | – | Sell |
-33,257
| Closed | -$972K | – | 1308 |
|
|
2022
Q4 | $972K | Buy |
33,257
+1,012
| +3% | +$29.6K | 0.03% | 314 |
|
|
2022
Q3 | $852K | Buy |
32,245
+1,499
| +5% | +$39.6K | 0.03% | 300 |
|
|
2022
Q2 | $1.37M | Buy |
30,746
+912
| +3% | +$40.5K | 0.04% | 232 |
|
|
2022
Q1 | $1.48M | Buy |
+29,834
| New | +$1.48M | 0.03% | 261 |
|
|
2021
Q3 | – | Sell |
-22,897
| Closed | -$980K | – | 1273 |
|
|
2021
Q2 | $980K | Buy |
22,897
+2,170
| +10% | +$92.9K | 0.03% | 329 |
|
|
2021
Q1 | $865K | Buy |
20,727
+6,573
| +46% | +$274K | 0.03% | 314 |
|
|
2020
Q4 | $659K | Buy |
14,154
+1,368
| +11% | +$63.7K | 0.03% | 294 |
|
|
2020
Q3 | $543K | Buy |
12,786
+7,113
| +125% | +$302K | 0.03% | 284 |
|
|
2020
Q2 | $272K | Buy |
+5,673
| New | +$272K | 0.05% | 412 |
|